There are 2867 resources available
405P - Repurposing disulfiram as treatment for irinotecan-resistant metastatic colorectal cancer: An investigator-initiated clinical phase II trial
Presenter: Line Tarpgaard
Session: Poster session 08
406P - Real-world evidence of efficacy and safety in first-line cetuximab treatment of RAS wild-type metastatic colorectal cancer: A multicenter retrospective study in Taiwan
Presenter: Chou-Chen Chen
Session: Poster session 08
407P - Cross-sectoral colorectal cancer care in Germany in the context of the COVID-19 pandemic and scarcity of resources
Presenter: Celine Lugnier
Session: Poster session 08
408P - Prediction of survival using the G8 scale frailty scale in a prospective series of elderly patients with colon cancer
Presenter: Gemma Soler Gonzalez
Session: Poster session 08
409P - Preliminary results of bevacizumab plus raltitrexed-based chemotherapy as second-line therapy in patients with metastatic colorectal cancer (mCRC): A multicenter phase II trial
Presenter: Sheng Li
Session: Poster session 08
411P - Laparoscopic versus open liver resection for colorectal cancer liver metastases: Five-year actual survival of the previously reported randomized controlled trial – The OSLO-COMET Trial
Presenter: Davit Aghayan
Session: Poster session 08
412P - Phase I study of intraperitoneal irinotecan in combination with standard systemic chemotherapy in patients with extensive peritoneal metastases of colorectal origin: The INTERACT trial
Presenter: Ruben Van Eerden
Session: Poster session 08
413P - Primary tumor resection (PTR) in metastatic colorectal cancer (mCRC) patients (pts) treated with upfront chemotherapy (CT) + bevacizumab (BEV): A pooled analysis of TRIBE and TRIBE2 studies
Presenter: Valentina Fanotto
Session: Poster session 08
414P - Long-term follow-up of the randomized trial of the conventional technique versus the no-touch isolation technique for primary tumor resection in patients with colon cancer ( JCOG1006)
Presenter: Yasumasa Takii
Session: Poster session 08